Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States

Journal of Hepatology

Volumn 58, Issue 2, 2013, Pages 212-216

  Baxa, Dwayne M ^a   Thekdi, Ashish D ^a   Golembieski, Alicia ^a   Krishnan, Prashant V ^a   Sharif, Omar ^a   Kizy, Anne ^a   Shetron Rama, Lynne ^c   Jovanovich, John ^b   Chappell, Brandi J ^b   Snow Lampart, Andrea ^b   Borroto Esoda, Katyna ^b   Gordon, Stuart C ^a  

^a HENRY FORD HOSPITAL   (United States)

^b GILEAD SCIENCES   (United States)

^c EASTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Acute infection; Drug resistance mutations; Hepatitis B virus

Indexed keywords

ADEFOVIR; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M; LAMIVUDINE; TENOFOVIR;

ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL ARTICLE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UNITED STATES; VIRUS MUTATION; VIRUS STRAIN;

ACUTE DISEASE; ADENINE; ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; GUANINE; HEPATITIS B; HUMANS; LAMIVUDINE; MALE; MUTATION; ORGANOPHOSPHONATES; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 84872419777     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.09.014     Document Type: Article

References (27)

1. R.G. Gish, and A.C. Gadano Chronic hepatitis B: current epidemiology in the Americas and implications for management J Viral Hepat 13 2006 787 798
2. C.M. Weinbaum, I. Williams, E.E. Mast, S.A. Wang, L. Finelli, and A. Wasley Recommendations for identification and public health management of persons with chronic hepatitis B virus infection MMWR Recomm Rep 57 2008 1 20
3. J.H. Kao, and D.S. Chen Global control of hepatitis B virus infection Lancet Infect Dis 2 2002 395 403
4. A. Wasley, D. Kruszon-Moran, W. Kuhnert, E.P. Simard, L. Finelli, and G. McQuillan The prevalence of hepatitis B virus infection in the United States in the era of vaccination J Infect Dis 202 2010 192 201
5. J.L. Dienstag, and B. Hepatitis Virus infection N Engl J Med 359 2008 1486 1500
6. F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 2009 1593 1608 e1591-1592
7. S.A. Whalley, J.M. Murray, D. Brown, G.J. Webster, V.C. Emery, and G.M. Dusheiko Kinetics of acute hepatitis B virus infection in humans J Exp Med 193 2001 847 854
8. S.G. Park, Y. Kim, E. Park, H.M. Ryu, and G. Jung Fidelity of hepatitis B virus polymerase Eur J Biochem 270 2003 2929 2936
9. K. Hayashi, Y. Katano, M. Ishigami, A. Itoh, Y. Hirooka, and I. Nakano Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains J Gastroenterol Hepatol 25 2010 745 749
10. R. Pastor, F. Habersetzer, S. Fafi-Kremer, M. Doffoel, T.F. Baumert, and J.P. Gut Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients World J Gastroenterol 15 2009 753 755
11. Z. Xu, Y. Liu, T. Xu, L. Chen, L. Si, and Y. Wang Acute hepatitis B infection associated with drug-resistant hepatitis B virus J Clin Virol 48 2010 270 274
12. T. Laskus, J. Rakela, and D.H. Persing The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring Hepatitis B virus variants Virology 200 1994 809 812
13. H.J. Yim, M. Hussain, Y. Liu, S.N. Wong, S.K. Fung, and A.S. Lok Evolution of multi-drug resistant hepatitis B virus during sequential therapy Hepatology 44 2006 703 712
14. H.M. Truong, R.M. Grant, W. McFarland, T. Kellogg, C. Kent, and B. Louie Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance AIDS 20 2006 2193 2197
15. E. Youmans, A. Tripathi, H. Albrecht, J.J. Gibson, and W.A. Duffus Transmitted antiretroviral drug resistance in individuals with newly diagnosed HIV infection: South Carolina 2005-2009 South Med J 104 2011 95 101
16. New DHHS guidelines for antiretroviral therapy. AIDS Alert 2010;25:21-24.
17. R.D. Sloan, A.L. Strang, M.E. Ramsay, and C.G. Teo Genotyping of acute HBV isolates from England, 1997-2001 J Clin Virol 44 2009 157 160
18. S. Margeridon, S. Carrouee-Durantel, I. Chemin, L. Barraud, F. Zoulim, and C. Trepo Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA Antimicrob Agents Chemother 52 2008 3068 3073
19. E. Sablon, and F. Shapiro Advances in molecular diagnosis of HBV infection and drug resistance Int J Med Sci 2 2005 8 16
20. B. Degertekin, M. Hussain, J. Tan, K. Oberhelman, and A.S. Lok Sensitivity and accuracy of an updated line probe assay (HBV DR v. 3) in detecting mutations associated with hepatitis B antiviral resistance J Hepatol 50 2009 42 48
21. J.J. Guo, Q.L. Li, X.F. Shi, D.Z. Zhang, A.Z. Zeng, and T. Feng Dynamics of hepatitis B virus resistance to entecavir in a nucleoside/nucleotide-naive patient Antiviral Res 81 2009 180 183
22. H. Okamoto, F. Tsuda, Y. Akahane, Y. Sugai, M. Yoshiba, and K. Moriyama Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen J Virol 68 1994 8102 8110
23. F. Rodriguez-Frias, M. Buti, R. Jardi, M. Cotrina, L. Viladomiu, and R. Esteban Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations Hepatology 22 1995 1641 1647
24. C. Hannoun, H. Norder, and M. Lindh An aberrant genotype revealed in recombinant hepatitis B virus strains from Vietnam J Gen Virol 81 Pt. 9 2000 2267 2272
25. M. Homs, M. Buti, J. Quer, R. Jardi, M. Schaper, and D. Tabernero Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome Nucleic Acids Res 39 2011 8457 8471
26. S. Margeridon-Thermet, N.S. Shulman, A. Ahmed, R. Shahriar, T. Liu, and C. Wang Ultra-deep pyrosequencing of hepatitis B virus quasi-species from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients J Infect Dis 199 2009 1275 1285
27. M. Solmone, D. Vincenti, M.C. Prosperi, A. Bruselles, G. Ippolito, and M.R. Capobianchi Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen J Virol 83 2009 1718 1726